Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Tamaris Clare Bucher has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14795894

METHODS OF TREATING DIABETES AND RELATED DISORDERS

IPC classification:
A61K 38/16, A61P 3/10
Applicant:
Novartis AG
Agent:
Tamaris Clare Bucher, Novartis AG
Status:
GRANT OF PATENT INTENDED
EP15710087

METHODS OF TREATING METABOLIC DISORDERS ASSOCIATED WITH LIPODYSTROPHIES AND DEFECTS IN INSULIN PRODUCTION OR SIGNALING

IPC classification:
A61K 38/18, A61K 39/395, A61P 1/16, A61P 3/06, A61P 3/08, A61P 3/10, A61K 47/50, A61K 47/69
Applicant:
Novartis AG
Agent:
Tamaris Clare Bucher, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15736046

COMPOSITIONS AND METHODS FOR VISUALIZATION OF THE VITREOUS

IPC classification:
A61K 47/42, A61K 49/00, A61P 41/00, C07K 14/47
Applicant:
Novartis AG
Agent:
Georg Kalhammer, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Tamaris Clare Bucher, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature